drugset / Trial / NCT02368210

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)

NCT02368210

Phase 3 Completed 151 enrolled Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This Phase 3 study (Study 306) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.

Timeline

Start
2015-01
Primary completion
2015-06
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject halobetasol propionate Small molecule 0.05 % Topical

Indications